Market Overview

Benzinga's Top Pre-Market Gainers

Related SCMP
China Food and Drug Administration Accepts IND for Pivotal Study of AMITIZA
Benzinga's Top Downgrades
Related BGMD
Earnings Scheduled For March 31, 2015
Earnings Scheduled For August 14, 2014

BG Medicine (NASDAQ: BGMD) soared 11.54% to $3.77 in the pre-market trading. BG Medicine obtained a CE Mark enabling the commercial sale of the CardioSCORE(TM) test in the EU.

Sucampo Pharmaceuticals (NASDAQ: SCMP) moved up 10.66% to $5.50 in the pre-market session. Sucampo Pharma received approval of an sNDA for RESCULA (unoprostone isopropyl ophthalmic solution) from the FDA.

Clearwire (NASDAQ: CLWR) added 5.60% to $2.83 in the pre-market session. Sprint Nextel (NYSE: S) is in talks to buy the 49% of Clearwire, according to people familiar with the matter.

Oncothyreon (NASDAQ: ONTY) surged 4.58% to $4.80 in the pre-market session. Oncothyreon's trailing-twelve-month ROE is -33.87%.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (CLWR + BGMD)

Around the Web, We're Loving...

Get Benzinga's Newsletters